Kinetic mechanism of protein arginine methyltransferase 1.
Protein arginine methyltransferases (PRMTs) are SAM-dependent enzymes that catalyze the mono- and dimethylation of peptidyl arginine residues. Although all PRMTs produce monomethyl arginine (MMA), type 1 PRMTs go on to form asymmetrically dimethylated arginine (ADMA), while type 2 enzymes form symmetrically dimethylated arginine (SDMA). PRMT1 is the major type 1 PRMT in vivo, thus it is the primary producer of the competitive NOS inhibitor, ADMA. Hence, potent inhibitors, which are highly selective for this particular isozyme, could serve as excellent therapeutics for heart disease. However, the design of such inhibitors is impeded by a lack of information regarding this enzyme's kinetic and catalytic mechanisms. Herein we report an analysis of the kinetic mechanism of human PRMT1 using both an unmethylated and a monomethylated substrate peptide based on the N-terminus of histone H4. The results of initial velocity and product and dead-end inhibition experiments indicate that PRMT1 utilizes a rapid equilibrium random mechanism with the formation of dead-end EAP and EBQ complexes. This mechanism is gratifyingly consistent with previous results demonstrating that PRMT1 catalyzes substrate dimethylation in a partially processive manner.
Obianyo
Obiamaka
O
Department of Chemistry & Biochemistry, University of South Carolina, 631 Sumter Street, Columbia, South Carolina 29208, USA.
Osborne
Tanesha C
TC
Thompson
Paul R
PR
D002384:Catalysis; D006331:Heart Diseases / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D007700:Kinetics; D008745:Methylation; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D011484:Protein-Arginine N-Methyltransferases / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*
D007527:Isoenzymes; D010446:Peptide Fragments; D011484:Protein-Arginine N-Methyltransferases
Biochemistry. 2007 Mar 27;46(12):3905-15
17338551
J Biol Chem. 2008 Apr 11;283(15):10015-25
18263580
Biochemistry. 1981 Mar 3;20(5):1204-10
7013788
J Am Chem Soc. 2008 Apr 9;130(14):4574-5
18338885
Basic Res Cardiol. 2006 Jul;101(4):346-53
16705470
J Biol Chem. 2001 Jan 12;276(2):1089-98
11050077
J Cell Sci. 2007 Dec 15;120(Pt 24):4243-6
18057026
Curr Biol. 2001 Jun 26;11(12):996-1000
11448779
Cell. 2004 Jun 11;117(6):735-48
15186775
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10848-53
10485914
Genes Dev. 2003 Apr 15;17(8):1019-29
12704081
Lancet. 1992 Mar 7;339(8793):572-5
1347093
Nat Struct Biol. 2000 Dec;7(12):1165-71
11101900
Atheroscler Suppl. 2003 Dec;4(4):33-40
14664901
Cancer. 2004 Jul 1;101(1):83-9
15221992
Dev Cell. 2007 Mar;12(3):443-55
17336909
Eukaryot Cell. 2007 Jun;6(6):889-98
17468392
Biochemistry. 2007 Nov 20;46(46):13370-81
17960915
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13527-32
12370443
Structure. 2003 May;11(5):509-20
12737817
Pharmacol Ther. 2007 Jan;113(1):50-87
17005254
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1023-30
15105281
J Biol Chem. 1973 Dec 25;248(24):8418-23
4797017
Biochem Biophys Res Commun. 2006 Apr 7;342(2):472-81
16487488
J Biol Chem. 1996 Jun 21;271(25):15034-44
8663146
Prostate. 2006 Sep 1;66(12):1292-301
16705743
J Mol Biol. 2008 Mar 28;377(3):668-78
18280497
Mol Cell. 2005 Apr 29;18(3):263-72
15866169
Nat Med. 2007 Feb;13(2):198-203
17273169
EMBO J. 2007 Oct 17;26(20):4402-12
17882261
EMBO J. 1997 Jan 15;16(2):260-6
9029147
Science. 2001 Aug 3;293(5531):853-7
11387442
Nature. 1997 Jun 12;387(6634):677-84
9192892
Science. 1997 Aug 15;277(5328):965-8
9252329
Circ Res. 2000 Jul 21;87(2):99-105
10903992
J Biol Chem. 1999 Nov 26;274(48):34283-93
10567404
EMBO J. 2000 Jul 17;19(14):3509-19
10899106